Search results for access to medicines

Bridging the global health equity gap: the impact of local biological manufacturing on patient access in Iran

Introduction/Study Objectives: Biological therapies have revolutionized the treatment of cancers, autoimmune, and metabolic diseases. However, access to these life-saving treatments remains severely limited in low- and middle-income countries due to high costs and infrastructure deficits. This study evaluates the impact of local manufacturing of biosimilars and complex biologicals on patient access in Iran, a lower-middle-income […]

Read more →

It is time to change US trade policy to foster access to medicines

Abstract: While Americans are deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generics industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore […]

Read more →

Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines

Abstract: The backlog in medicines registration in South Africa is a result of the implementation of pro-generics policies without strengthening the regulator to handle the substantial increase in registration applications that followed. Despite the backlog, more than enough generics are registered to promote price competition and ensure access to affordable medicines. Submitted: 25 February 2015; […]

Read more →